HealthEquity (NASDAQ:HQY) Releases FY 2027 Earnings Guidance

HealthEquity (NASDAQ:HQY) updated its FY 2027 earnings guidance on Thursday. The company provided EPS guidance of 4.660-4.730 for the period, compared to the consensus EPS estimate of 4.560. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion.

HealthEquity Stock Down 0.9%

HQY stock opened at $104.42 on Thursday. The stock has a market capitalization of $8.73 billion, a P/E ratio of 39.11, a P/E/G ratio of 1.77 and a beta of 0.21. The business has a fifty day moving average price of $97.77 and a 200-day moving average price of $87.71. HealthEquity has a 1-year low of $72.76 and a 1-year high of $107.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. The business had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The company’s revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts forecast that HealthEquity will post 3.92 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HQY shares. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, August 22nd. Barrington Research restated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a report on Friday, May 22nd. Royal Bank Of Canada upped their target price on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Finally, Citizens Jmp raised their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.93.

Insiders Place Their Bets

In other news, EVP Michael Henry Fiore sold 2,354 shares of the business’s stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the transaction, the executive vice president owned 52,244 shares of the company’s stock, valued at approximately $4,963,180. The trade was a 4.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 7,966 shares of company stock worth $756,770. 1.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently bought and sold shares of the business. Acumen Wealth Advisors LLC bought a new position in HealthEquity in the fourth quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new position in HealthEquity during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd lifted its stake in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of HealthEquity by 190.4% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after purchasing an additional 396 shares during the last quarter. Finally, Larson Financial Group LLC raised its holdings in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.